OVARIAN CANCER and US

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, September 07, 2012

The authors respond: Consent requirements for pelvic examinations



The authors respond

CMAJ September 4, 2012 vol. 184 no. 12 doi: 10.1503/cmaj.112-2052
  • Letters

The authors respond

  1. Jocelyn Downie, SJD
+ Author Affiliations
  1. The Health Law Institute, Dalhousie University, Halifax, NS
Margaret Morris has missed the point of our article.1,2 We agree that some residents conduct pelvic examinations solely for therapeutic purposes (i.e., they are fully trained in conducting such examinations and the only purpose for the examination is the care of the patient) and the policy statement does not fail in relation to such residents. However, Morris ignores the fact (explained in our article) that some residents are conducting pelvic examinations solely for training purposes, or for a combination of therapeutic and training purposes. Our considered view, grounded in a careful review of the relevant law, is that patients must be asked for explicit consent to a resident’s performing a pelvic examination in whole or in part for training purposes. On this narrow point we took issue with the revisions to the policy statement3 because of its shift from covering residents and medical students in this context to only covering medical students. We argued, and continue to hold, that residents should either be added back into the policy statement in relation to the conduct of pelvic examinations for training purposes, or a separate policy for residents (requiring disclosure of purpose and explicit consent for such examinations) should be developed.
We share Morris’ goals of achieving “the best possible care for women in the academic environment” and ensuring that “all health professionals providing care for women are adequately trained.” However, we do not agree that calling for disclosure of training purposes and explicit consent in residents performing pelvic examinations for training purposes can be characterized as “needlessly raising anxiety in the public and putting the clinical academic process in jeopardy.” In a study conducted at the Calgary Pelvic Floor Disorders Clinic, a majority of women surveyed indicated that they would consent to a pelvic examination for training purposes if asked.4 Further, even if the result would be fewer patients agreeing to have such examinations conducted, this is no justification for overriding legal rights and ignoring ethical responsibilities.

References

Consent requirements for pelvic examinations



Consent requirements for pelvic examinations

CMAJ September 4, 2012 vol. 184 no. 12 doi: 10.1503/cmaj.112-2061
  • Letters

Consent requirements for pelvic examinations

  1. Margaret L. Morris, MD, President
+ Author Affiliations
  1. The Association of Academic Professionals in Obstetrics and Gynaecology, Ottawa, Ont.
The board of the Association of Academic Professionals in Obstetrics and Gynaecology (APOG, formerly the Association of Professors of Obstetrics and Gynaecology of Canada) wishes to respond to the CMAJ article by Gibson and Downie,1 which revisits the issue of consent prior to pelvic examination. As the academic organization responsible for support for the academic missions in undergraduate and postgraduate training in obstetrics and gynecology, we have serious concerns.
“Medical trainees” was changed to “medical students” in the revised guidelines,2 which identifies the medical student’s role in pelvic examination as a learner. The new document is patient-focused and clearly defines informed consent on the part of the medical student and the entire gynecologic surgical team. The document ensures that patients are fully informed about the medical student’s role as a learner during clinical care and that patients may opt out of being a participant in the teaching of pelvic examination skills.
Gibson and Downie1 expressed concerns about the comprehensiveness of the guideline with regard to the exclusion of residents as medical trainees. Residents are physicians who are qualified medical practitioners and are deemed to have developed their pelvic examination skills to the point where they are able perform them independently — as well as offer supervision to learners. Residents are employed under contract by provincial bodies responsible for residency programs. Under ethical obligations set down by provincial governing bodies, qualified physician residents provide care only with patient consent. Residents certainly continue to learn and acquire experience as do all obstetrician–gynecologists who have already completed their training. The principle of lifelong learning is important for all physicians.
Our Association welcomes input and membership from all interested stakeholders including those from the legal community. We strive to achieve the best possible care for women in the academic environment, while fulfilling our commitment to ensure all health professionals providing care for women are adequately trained. Ideally, this should be carried out in a safe environment for both the learner and the patient without needlessly raising anxiety in the public and putting the clinical academic process in jeopardy. A collaborative approach between legal colleagues and physicians would be much more productive toward achieving this goal.

References

Articles citing this article

consent requirements for pelvic examinations performed - Google Search





consent requirements for pelvic examinations performed - Google Search



46th Anniversary of Star Trek




  1. search results within past year = 30,500;
Screen-reader users, click here to turn off Google Instan overall (no limitations) Search:
About 389,000 results (0.38 seconds) 

Replies to Consent requirements for pelvic examinations performed for training purposes



Replies to Consent requirements for pelvic examinations performed for training purposes

  1. Response to APOG Letter of May 14, 2012

    We are writing in response to the letter to the editor by Margaret Morris on behalf of the Board of the Association of Professors of Obstetrics and Gynaecology of Canada (APOG) dated May 14, 2012, which was in turn a response to our CMAJ article of March 26, 2012. Ms Morris has missed the point of our article. We agree with Ms Morris that More...
    Submit response
  2. Response to Consent Requirements for pelvic examinations performed for training purposes as they revisit the issue of consent prior to pelvic examination.

    The board of APOG is writing in response to the article by Ms. Gibson and Ms. Downie, Consent requirements for pelvic examination performed for training purposes as they revisit the issue of consent prior to pelvic examination. As the academic organization responsible for support for the academic missions in undergraduate and postgraduate More...
    Submit response
  3. Regulatory policy requires specific consent

    I write on behalf of the College of Physicians and Surgeons of Ontario, in response to the recent article in CMAJ "Consent requirements for pelvic examinations performed for training purposes" (CMAJ, March 26, 2012). We appreciate that the authors of this article were only commenting on new policy guidelines from More...
    Submit response

Women's College Research Institute - An innovative solution for women with gynecological cancer



An innovative solution for women with gynecological cancer




Sent from my iPhone

Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion



Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion

Cover image for Vol. 52 Issue 4

Australian and New Zealand Journal of Obstetrics and Gynaecology






Sent from my iPhone

Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?




Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?



OBJECTIVE: Our aim was to examine the clinicopathologic characteristics and survival of ovarian, tubal, and peritoneal (further denoted "adnexal") cancer in BRCA1 compared with BRCA2 carriers.





METHODS: A consecutive series of adnexal cancers in BRCA1/2 mutation carriers diagnosed in 1980 to 2010 at the University Medical Center Groningen was analyzed.

RESULTS: We evaluated 55 BRCA1- and 16 BRCA2-related adnexal cancers, consisting of 51 ovarian, 13 tubal, and 7 peritoneal cancers. Peritoneal cancer was restricted to BRCA1 carriers. Ovarian and tubal cancer was equally present in both carrier groups. Median age at diagnosis was younger in BRCA1 compared with BRCA2 carriers (50 vs 54 years; P = 0.03). No other clinicopathologic differences were found. Regarding survival, a nonsignificant trend was noted for BRCA2 carriers to have fewer relapses, a longer time to first relapse, and a longer disease-free and overall survival.

CONCLUSIONS: Except for age at diagnosis and prevalence of peritoneal cancer, no significant clinicopathologic differences were found between BRCA1- versus BRCA2-associated adnexal cancer. On survival, it might be suggested that BRCA2 carriers have a more favorable outcome than BRCA1 carriers, marked by fewer relapses, a longer time to first relapse, and a longer disease-free and overall survival.



Sent from my iPhone

Elevated carbohydrate antigen 125 level




Elevated carbohydrate antigen 125 levels in patients with aortic stenosis: relation to clinical severity and echocardiographic parameters.



Sent from my iPhone

AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer - Full Text View - ClinicalTrials.gov



http://clinicaltrials.gov/ct2/show/NCT00976911?term=ovarian+cancer&recr=Open&lup_s=08%2F08%2F2012&lup_d=30


Sent from my iPhone

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer - Full Text View - ClinicalTrials.gov



http://clinicaltrials.gov/ct2/show/NCT01681368?term=ovarian+cancer&recr=Open&lup_s=08%2F08%2F2012&lup_d=30


Sent from my iPhone

BMC Medical Informatics and Decision Making | Abstract | Boundaries and e-health implementation in health and social care




Open AccessResearch article

Boundaries and e-health implementation in health and social care


BMC Medical Informatics and Decision Making 2012,12:100 doi:10.1186/1472-6947-12-100

Published: 7 September 2012


Sent from my iPhone

Job Posting Director of Events and Development Manager | Ovarian Cancer National Alliance



http://www.ovariancancer.org/2012/09/06/were-hiring-director-of-events-and-development-manager/


Sent from my iPhone

Court: You Can Appeal Medicare Decisions About Hospice Services - NYTimes.com



http://newoldage.blogs.nytimes.com/2012/09/07/court-affirms-right-to-appeal-medicare-decisions-about-hospice-services/?partner=rss&emc=rss


Sent from my iPhone

Can Canada reckon with its health costs? : The Lancet



http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2961490-1/fulltext?elsca1=ETOC-LANCET&elsca2=email&elsca3=E24A35F


Sent from my iPhone

The struggle for universal health coverage : The Lancet



.....These debates should be informed by the 2010 World Health Report by David Evans and colleagues, one of the most important publications from WHO in a decade, which sets out the how and why of improved health gains and efficiencies from UHC. Efficiencies include better health outcomes, according to Rodrigo Moreno-Serra and Peter Smith, especially for the least advantaged in a society. Debates should also examine the evidence, as has Jeffrey Sachs' Viewpoint, about the obstacle raised by user fees. Regardless of the euphemism chosen to describe shared payments, they are in reality a locked gate that prevents access to health care for many who need it most. They should be scrapped...…




Sent from my iPhone

Compassionate use of experimental drugs possible in cancer treatment - MayoClinic.com



http://www.mayoclinic.com/health/experimental-drugs-and-cancer/MY02223/?utm_source=newsletter&utm_medium=email&utm_campaign=living-with-cancer&pubDate=09/06/2012


Sent from my iPhone

Thursday, September 06, 2012

Not a Cancer Survivor - NYTimes.com



http://well.blogs.nytimes.com/2012/09/06/not-a-cancer-survivor/?partner=rss&emc=rss


Sent from my iPhone

18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer



http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01608009


Sent from my iPhone

ENCODE: The human encyclopaedia : Nature News & Comment



http://www.nature.com/news/encode-the-human-encyclopaedia-1.11312


Sent from my iPhone

Exercise interventions on health-related quality of life for people with cancer during active treatment - The Cochrane Library - Mishra - Wiley Online Library



Intervention Review

Exercise interventions on health-related quality of life for people with cancer during active treatment


Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 15 AUG 2012

Assessed as up-to-date: 1 JUN 2012

DOI: 10.1002/14651858.CD008465.pub2




Sent from my iPhone

Can exercise interventions enhance health-related quality of life among cancer survivors? | Cochrane Summaries



http://summaries.cochrane.org/CD007566/can-exercise-interventions-enhance-health-related-quality-of-life-among-cancer-survivors


Sent from my iPhone

Genetics and Ovarian Cancer: What You Should Know




Genetics and Ovarian Cancer: What You Should Know


Wednesday, September 19, 2012 2:00 PM - 3:00 PM EDT

Webinar Registration

About 10 to 15 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease. Women with mutations in the breast cancer genes (BRCA 1 and 2), as well as HNPCC or Lynch syndrome, are more likely to develop ovarian cancer.

Experts from three groups that work on genetic issues related to cancer will join us for a webinar kicking off National Hereditary Breast and Ovarian Cancer week.

* Rebecca Sutphen, MD, FACMG, of FORCE will talk about family history and how that relates to cancer.
* Amber P. Trivedi, MS, CGC, from Bright Pink will discuss psychosocial issues around hereditary cancer, including fertility issues and prophylactic surgery.
* Shera Dubitsky, MEd, MA, Clinical Supervisor at Sharsheret, will discuss how to talk with your family about hereditary cancer risk.

Whether you know your personal genetic risk, work with women at high risk of developing ovarian cancer or just want to learn more about this topic, we urge you to RSVP today for our free session.

*  
*  
*   

* Indicates a required field

By clicking the "Register Now" button you submit your information to the Webinar organizer, who will use it to communicate with you regarding this event and their other services.




Sent from my iPhone